Skip to main content

Companies researching CAR-T Cell Therapy

CAR‑T cell therapy engineers a patient's T cells to express chimeric antigen receptors, enabling them to identify and eliminate cancer cells, and is often classified as a cell‑based gene therapy.

List of companies that research CAR-T Cell Therapy

This is sourced from job postings — companies only hire for what they actively use or plan to adopt · how we source this →

  • Johnson & Johnson logo
    United StatesEmployees138kRevenue$94BHospitals and Health Care
    CAR-T Cell TherapyHigh confidence
  • Bristol Myers Squibb logo
    United StatesEmployees39kRevenue$46BPharmaceutical Manufacturing
    CAR-T Cell TherapyHigh confidence
  • Rutgers University logo
    United StatesEmployees18kRevenue$5.1BHigher Education
    CAR-T Cell TherapyHigh confidence
  • Kite Pharma logo
    United StatesEmployees4.1kRevenue$45MBiotechnology Research
    CAR-T Cell TherapyHigh confidence
  • UW Health logo
    United StatesEmployees21kRevenue$3.8BHospitals and Health Care
    CAR-T Cell TherapyHigh confidence
  • Texas Oncology logo
    United StatesEmployees4.2kRevenue$500MHospitals and Health Care
    CAR-T Cell TherapyHigh confidence
  • City of Hope logo
    United StatesEmployees13kRevenue$2.4BHospitals and Health Care
    CAR-T Cell TherapyHigh confidence
  • Gilead Sciences logo
    United StatesEmployees15kRevenue$27BBiotechnology Research
    CAR-T Cell TherapyHigh confidence
  • Kyverna Therapeutics logo
    United StatesEmployees187Revenue$2.9MBiotechnology Research
    CAR-T Cell TherapyHigh confidence
  • Penn State Health logo
    United StatesEmployees10kRevenue$4.3BHospitals and Health Care
    CAR-T Cell TherapyHigh confidence

Showing top companies out of 632 that research CAR-T Cell Therapy. Get the full list on TheirStack.

Frequently asked questions